Clinical trial

Study of Novel Treatment Combinations in Patients With Lung Cancer

NCT05633667

Study summary

ClinicalTrials.gov

Study of Novel Treatment Combinations in Patients With Lung Cancer

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

11 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Zimberelimab (ZIM) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Domvanalimab (DOM) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Sacituzumab govitecan-hziy (SG) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Etrumadenant (ETRUMA) Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cisplatin Normalized identity: cisplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pemetrexed Normalized identity: pemetrexed View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxel View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Nab-paclitaxel Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Docetaxel Normalized identity: docetaxel View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Nivolumab Normalized identity: nivolumab View linked drug · Find medicine records · Find other trials using this name

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2023-03-16

PhasePHASE2

Conditions

Lung Cancerverified · MONDO: lung cancer

Advanced or Metastatic Non-Small-Cell Lung Cancerunresolved

Resectable Non-Small-Cell Lung Cancerunresolved

Interventions

Zimberelimab (ZIM)DRUG

Domvanalimab (DOM)DRUG

Sacituzumab govitecan-hziy (SG)DRUG

Etrumadenant (ETRUMA)DRUG

CarboplatinDRUG · verified · RxNorm: carboplatin

CisplatinDRUG · verified · RxNorm: cisplatin

PemetrexedDRUG · verified · RxNorm: pemetrexed

PaclitaxelDRUG · verified · RxNorm: paclitaxel

Nab-paclitaxelDRUG

DocetaxelDRUG · verified · RxNorm: docetaxel

NivolumabDRUG · verified · RxNorm: nivolumab

Sponsors & collaborators

Gilead Scienceslead sponsor

Arcus Biosciences, Inc.collaborator

Mapped research locations

SeoulSouth Korea12 Kaohsiung CityTaiwan6 JerusalemIsrael5 Porto AlegreBrazil5 St LouisMissouri, United States4 São PauloBrazil4 Hong KongHong Kong4 LondonUnited Kingdom3 HaifaIsrael3 Tel AvivIsrael3 BirminghamUnited Kingdom3 ChanghuaTaiwan3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05633667 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.